Pharmacology

Resource Center

Research Summaries

Enzyme Replacement Therapy
Enzyme Replacement Therapy
03/17/2023
Jessica Ganga
Following a multicenter study, the FDA has approved the first enzyme replacement therapy in the United States to treat alpha-mannosidosis.
03/17/2023
Research Summary
Research Summary
02/28/2023
The researchers evaluated the effects of two medications used for type 2 diabetes patients on reducing major cardiovascular events in both men and women.
02/28/2023
Research Summary
Research Summary
02/27/2023
Researchers examined the association between inflammation-reducing medications and dementia risk in patients with rheumatoid arthritis.
02/27/2023
Research Summary
Research Summary
02/23/2023
The American Heart Association (AHA) addresses the adverse effect of hypertension in patients receiving anticancer therapies and how the disease should be managed.
02/23/2023
Fractures
Fractures
02/02/2023
The researchers compared the efficacy of thromboprophylaxis with aspirin to low-molecular-weight heparin in patients with orthopedic trauma.
02/02/2023
Symptom Management
Symptom Management
01/31/2023
The American Heart Association (AHA) released a statement regarding the use of complementary and alternative treatments that are used in the United States for the treatment of heart failure symptoms.
01/31/2023
Retinopathy
eye
Retinopathy
01/26/2023
Researchers examined the risk of patients developing retinopathy after long-term use of hydroxychloroquine.
01/26/2023
Treatment
Treatment
01/13/2023
The American College of Physicians updated its set of guidelines on the pharmacologic treatment of primary osteoporosis based on current evidence and research.
01/13/2023
Research Summary
Research Summary
09/22/2022
Researchers sought to better understand the relationship between early-life exposure to antibiotics and later onset of atopic dermatitis in children.
09/22/2022
FDA Alert
FDA Alert
12/10/2015
Kate Young
The FDA has granted accelerated approval to linvoseltamab-gcpt, a BCMA-directed bispecific T-cell engager, offering a new option for patients with heavily pretreated relapsed or refractory multiple myeloma....
12/10/2015